General information about company
Scrip code	506854
NSE Symbol
MSEI Symbol
ISIN*	INE639B01015
Name of company	TANFAC INDUSTRIES LIMITED
Type of company
Class of security	Equity
Date of start of financial year	01-04-2022
Date of end of financial year	31-03-2023
Date of board meeting when results were approved	21-04-2023
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	12-04-2023
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Quarter	Yearly
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited	Audited
Segment Reporting	Single segment
Description of single segment	CHEMICAL
Start date and time of board meeting	21-04-2023 16:00
End date and time of board meeting	21-04-2023 17:30
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2023	01-04-2022
B	Date of end of reporting period	31-03-2023	31-03-2023
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	11552.965	37494.811
	Other income	629.415	792.175
	Total income	12182.38	38286.986
2	Expenses
(a)	Cost of materials consumed	6797.009	22880.952
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	45.445	-206.075
(d)	Employee benefit expense	451.447	1629.842
(e)	Finance costs	30.843	88.428
(f)	Depreciation, depletion and amortisation expense	171.431	633.271
(f)	Other Expenses
1	Power & Fuel	436.792	1603.945
2	Other Expenses	1239.445	4110.381
10
	Total other expenses	1676.237	5714.326
	Total expenses	9172.412	30740.744

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2023	01-04-2022
B	Date of end of reporting period	31-03-2023	31-03-2023
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
3	Total profit before exceptional items and tax	3009.968	7546.242
4	Exceptional items	0	0
5	Total profit before tax	3009.968	7546.242
7	Tax expense
8	Current tax	769.24	1935.81
9	Deferred tax	2.91	-2.546
10	Total tax expenses	772.15	1933.264
11	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
14	Net Profit Loss for the period from continuing operations	2237.818	5612.978
15	Profit (loss) from discontinued operations before tax	0	0
16	Tax expense of discontinued operations	0	0
17	Net profit (loss) from discontinued operation after tax	0	0
19	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
21	Total profit (loss) for period	2237.818	5612.978
22	Other comprehensive income net of taxes	1.72	-6.2

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2023	01-04-2022
B	Date of end of reporting period	31-03-2023	31-03-2023
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
23	Total Comprehensive Income for the period	2239.538	5606.778
24	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
25	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	0	0
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
26	Details of equity share capital
	Paid-up equity share capital	997.5	997.5
	Face value of equity share capital	10	10
27	Details of debt securities
28	Reserves excluding revaluation reserve		0
29	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	22.43	56.27
	Diluted earnings (loss) per share from continuing operations	22.43	56.27
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	22.43	56.27
	Diluted earnings (loss) per share from continuing and discontinued operations	22.43	56.27
30	Debt equity ratio
31	Debt service coverage ratio
32	Interest service coverage ratio
33	Disclosure of notes on financial results	Textual Information(1)

Text Block

Textual Information(1)

1. The above audited financial results were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on 21st April 2023. 2.The company operates in a single segment i.e, Chemicals in India and all other activities evolve around the same. Hence, there is no reportable primary/ secondary segment in accordance with the requirements of Ind AS 108, 'Operating Segments'. 3.# Figures of the last quarter are the balancing figures between audited figures in respect of the full financial year and published year to date reviewed figures upto the 3rd quarter of the relevant financial year. 4.The Board of Directors, in their meeting held on 21st April 2023, have recommended dividend of Rs.6.50/- per equity share of face value of Rs.10/- each for the financial year 2022-23 subject to approval by members in the ensuing Annual General Meeting (Previous Year Rs.5.50/- per Equity Share). 5.The Board of Directors, at its meeting held on 10th February 2023, have accorded its approval to the Company's expansion project for doubling its existing capacity of Hydrofluoric Acid Plant at Cuddalore at an estimated cost of around Rs.100 Crores to be implemented over the period of 15 to 18 months. 6.Other Income of Rs. 629.41 Lakhs during the quarter ending March'23 includes an amount of Rs.440.90 Lakhs towards Claims admitted by a Raw Material supplier for non supply of Purchase Order quantity as per the Contract terms. 7. Figures for the previous period / year have been rearranged /reclassified wherever necessary, to correspond with current period / year presentation.

Statement of Asset and Liabilities
Particulars		Current year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2022
Date of end of reporting period		31-03-2023
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	5471.04
	Capital work-in-progress	593.03
	Investment property
	Goodwill	0
	Other intangible assets	0
	Intangible assets under development
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	141.93
	Trade receivables, non-current
	Loans, non-current	0
	Other non-current financial assets	13.09
	Total non-current financial assets	155.02
	Deferred tax assets (net)
	Other non-current assets	82.55
	Total non-current assets	6301.64
2	Current assets
	Inventories	5292.9
	Current financial asset
	Current investments	6562.37
	Trade receivables, current	5077.85
	Cash and cash equivalents	389.73
	Bank balance other than cash and cash equivalents	878.27
	Loans, current	0
	Other current financial assets	0.75
	Total current financial assets	12908.97
	Current tax assets (net)	68.47
	Other current assets	608.93
	Total current assets	18879.27

Statement of Asset and Liabilities
Particulars		Current year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2022
Date of end of reporting period		31-03-2023
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	25180.91
	Equity and liabilities
	Equity
	Equity attributable to owners of parent
	Equity share capital	997.5
	Other equity	17429.963
	Total equity attributable to owners of parent	18427.463
	Non controlling interest
	Total equity	18427.463
	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	Other non-current financial liabilities
	Total non-current financial liabilities	0
	Provisions, non-current	110.38
	Deferred tax liabilities (net)	317.4
	Deferred government grants, Non-current
	Other non-current liabilities
	Total non-current liabilities	427.78
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current	4639.23
	Other current financial liabilities
	Total current financial liabilities	4639.23
	Other current liabilities	553.647
	Provisions, current	1026.941
	Current tax liabilities (Net)	105.849
	Deferred government grants, Current
	Total current liabilities	6325.667
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	6753.447
	Total equity and liabilites	25180.91
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-01-2023	01-04-2022
Date of end of reporting period		31-03-2023	31-03-2023
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets
	Net Segment Asset
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities
	Net Segment Liabilities
	Disclosure of notes on segments

Cash flow statement, indirect
Particulars		Year ended (dd-mm-yyyy)
A	Date of start of reporting period	01-04-2022
B	Date of end of reporting period	31-03-2023
C	Whether results are audited or unaudited	Audited
D	Nature of report standalone or consolidated	Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax	7546.242
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs	88.428
	Adjustments for decrease (increase) in inventories	-1145.717
	Adjustments for decrease (increase) in trade receivables, current	-2524.04
	Adjustments for decrease (increase) in trade receivables, non-current	0
	Adjustments for decrease (increase) in other current assets	-186.88
	Adjustments for decrease (increase) in other non-current assets	0
	Adjustments for other financial assets, non-current	0
	Adjustments for other financial assets, current	0
	Adjustments for other bank balances	0
	Adjustments for increase (decrease) in trade payables, current	1725.88
	Adjustments for increase (decrease) in trade payables, non-current	0
	Adjustments for increase (decrease) in other current liabilities	0
	Adjustments for increase (decrease) in other non-current liabilities	0
	Adjustments for depreciation and amortisation expense	633.271
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss	0
	Adjustments for provisions, current	-36.45
	Adjustments for provisions, non-current	0
	Adjustments for other financial liabilities, current	0
	Adjustments for other financial liabilities, non-current	0
	Adjustments for unrealised foreign exchange losses gains	23.49
	Adjustments for dividend income	0
	Adjustments for interest income	30.589
	Adjustments for share-based payments	0
	Adjustments for fair value losses (gains)	54.41
	Adjustments for undistributed profits of associates	0
	Other adjustments for which cash effects are investing or financing cash flow	0
	Other adjustments to reconcile profit (loss)	-131.413
	Other adjustments for non-cash items	0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships	0
	Total adjustments for reconcile profit (loss)	-1529.61
	Net cash flows from (used in) operations	6016.632
	Dividends received	0
	Interest paid	0
	Interest received	0
	Income taxes paid (refund)	1722.762
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) operating activities	4293.87
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses	0
	Cash flows used in obtaining control of subsidiaries or other businesses	0
	Other cash receipts from sales of equity or debt instruments of other entities	0
	Other cash payments to acquire equity or debt instruments of other entities	0
	Other cash receipts from sales of interests in joint ventures	0
	Other cash payments to acquire interests in joint ventures	0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships	0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships	0
	Proceeds from sales of property, plant and equipment	10.05
	Purchase of property, plant and equipment	1491.079
	Proceeds from sales of investment property	11415.36
	Purchase of investment property	13924.32
	Proceeds from sales of intangible assets	0
	Purchase of intangible assets	0
	Proceeds from sales of intangible assets under development	0
	Purchase of intangible assets under development	0
	Proceeds from sales of goodwill	0
	Purchase of goodwill	0
	Proceeds from biological assets other than bearer plants	0
	Purchase of biological assets other than bearer plants	0
	Proceeds from government grants	0
	Proceeds from sales of other long-term assets	0
	Purchase of other long-term assets	0
	Cash advances and loans made to other parties	0
	Cash receipts from repayment of advances and loans made to other parties	0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts	0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts	0
	Dividends received	0
	Interest received	30.589
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	-0.01
	Net cash flows from (used in) investing activities	-3959.41
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries	0
	Payments from changes in ownership interests in subsidiaries	0
	Proceeds from issuing shares	0
	Proceeds from issuing other equity instruments	0
	Payments to acquire or redeem entity's shares	0
	Payments of other equity instruments	0
	Proceeds from exercise of stock options	0
	Proceeds from issuing debentures notes bonds etc	0
	Proceeds from borrowings	0
	Repayments of borrowings	0
	Payments of finance lease liabilities	0
	Payments of lease liabilities	0
	Dividends paid	548.625
	Interest paid	88.428
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) financing activities	-637.053
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes	-302.593
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents	0
	Net increase (decrease) in cash and cash equivalents	-302.593
	Cash and cash equivalents cash flow statement at beginning of period	692.332
	Cash and cash equivalents cash flow statement at end of period	389.739